Crystalline Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Crystalline Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$929K	–	147
2023 Q2	$929K	Buy	+20,000	New	+$691K	0.66%	52

Crystalline Management's DICE Position: Q3 2023 in Review

Crystalline Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 20,000 shares — an estimated $929K sold.

Crystalline Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $929K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Crystalline Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Crystalline Management sold 20,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $929K.
Crystalline Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Crystalline Management's DICE Therapeutics, Inc. Common Stock position peaked at $929K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Crystalline Management's 13F filing for Q3 2023, filed 13 Nov 2023.